Researchers have discovered that dormant breast cancer cells can be detected and wiped out with existing drugs, dramatically lowering the risk of relapse. The breakthrough brings new hope to survivors haunted by the fear of recurrence. Breakthrough Trial Targets Dormant Breast Cancer Cells A landmark federally funded clinical trial has provided the first real evidence […]



Summary

A groundbreaking clinical trial has shown that dormant breast cancer cells, the leading cause of relapse, can be targeted and eliminated using existing drugs. This provides significant hope for breast cancer survivors living with the constant threat of recurrence. Researchers found that specific treatments can successfully eradicate these lingering cells, drastically reducing the chances of the cancer returning. This federally funded study marks a major advancement in breast cancer treatment and offers a new strategy for improving long-term outcomes for patients.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer